ASCRS 2020: Eyevance portfolio brimming with product launches

Article
Conferences|ASCRS

Ophthalmology Times' Sheryl Stevenson speaks with Julie Speed, chief commercial officer of Eyevance Pharmaceuticals, on what's on the agenda for the company's porfolio this year with product launches during the 2020 ASCRS virtual meeting.
 

 

See more ASCRS coverage here

Recent Videos
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Related Content
ASCRS looks forward during milestone meeting

ASCRS looks forward during milestone meeting

Article
Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment

Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment

Podcast
Liver function test changes after fungal keratitis treatment

Liver function test changes after fungal keratitis treatment

Article
EyePod

ASCRS 2020: Assessing aberration of monofocal toric IOL with enhanced optic recovery, alignment

Podcast
Measuring biomarkers may Identify patients at risk of retinal vascular progression after cataract surgery

Measuring biomarkers may Identify patients at risk of retinal vascular progression after cataract surgery

Article
Possible role of face masks in increased incidence of infectious keratitis after PRK during COVID

Possible role of face masks in increased incidence of infectious keratitis after PRK during COVID

Article
© 2024 MJH Life Sciences

All rights reserved.